Atlas Trials

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

Clinical trial NCT06891040 · COMPLETED

Trial details

NCT number
NCT06891040
Sponsor
Jiangsu vcare pharmaceutical technology co., LTD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2025-04-28
Primary completion
2025-10-31
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.